You are here

generics

12,000 diseases lack treatments. One doctor thinks generics could yield cures

Stat

Thu, 05/4/23 - 08:57 pm

orphan diseases

artificial intelligence

Sanders, Cassidy reach deal to increase access to generic prescription drugs, reform PBMs

Fierce Healthcare

Tue, 04/25/23 - 10:13 pm

Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028

Fierce Pharma

Thu, 04/20/23 - 11:47 am

Takeda hit with another pay-for-delay lawsuit, this time on gout drug Colcrys

Fierce Pharma

Wed, 04/12/23 - 10:07 pm

Four Trends That Will Pop the $250 Billion Gross-to-Net Bubble—and Transform PBMs, Market Access, and Benefit Design

Drug Channels

Tue, 04/4/23 - 10:16 am

Biogen gets EU court ruling in favor of blocking Tecfidera generic entry

Seeking Alpha

Thu, 03/16/23 - 09:44 am

multiple sclerosis

Jazz loses appeal, will have patent delisted from the Orange Book

Endpoints

Mon, 02/27/23 - 07:09 pm

Dr. Reddy's to buy Mayne Pharma’s US generics drug list for at least $90M

Endpoints

Mon, 02/27/23 - 10:04 am

In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics

Fierce Pharma

Fri, 02/24/23 - 08:55 am

Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication

Endpoints

Mon, 02/13/23 - 10:01 pm

product recalls

Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio

Endpoints

Wed, 01/25/23 - 10:44 am

Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent

Endpoints

Tue, 01/24/23 - 06:18 pm

multiple sclerosis

Jazz sues generics makers for infringement on cannabis-derived epilepsy drug

Fierce Pharma

Thu, 01/5/23 - 05:00 pm

Novartis to pay $245 mln to end antitrust cases over Exforge drug generics

Reuters

Thu, 01/5/23 - 09:57 am

Mark Cuban’s Cost Plus Drug Company Continues To Revolutionize Generic Drug Pricing

Forbes

Mon, 01/2/23 - 06:28 pm

Mark Cuban Cost Plus Drugs

Bags of shredded docs: Indian drugmaker Lupin handed a Form 483 by FDA inspectors

Endpoints

Sun, 12/11/22 - 01:29 pm

FDA preps for DMD drug generics as Sarepta has yet to finish its confirmatory trial

Endpoints

Sat, 11/26/22 - 07:15 pm

Sarepta Therapeutics

Duchenne Muscular Dystrophy

'Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says

Fierce Pharma

Wed, 11/23/22 - 07:33 am

Bristol Myers Squibb

FDA sees room for growth for complex generics

RAPS.org

Mon, 11/14/22 - 07:07 pm

complex generics

AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others

Endpoints

Mon, 10/31/22 - 04:22 pm

Teva Pharmaceuticals

Pages